To follow up on the Arm IPO story above, we identified a clear example of why investors may be hesitant to take part in IPOs this year. 😰
Below is Bruuush Oral Care, which came public on the Nasdaq in August 2022. After a slight pop on its second day of trading, prices peaked at a pre-25-for-1 reverse split price of $97 and have been falling ever since. The stock hit an all-time low of $1.25 yesterday, making today’s post-earnings rally of 33% barely noticeable on the chart.
Until fewer of these situations happen, investors will likely remain cautious about companies bringing their shares to market. And we don’t blame them.
Anyway, we hope you’re enjoying the ride $BRSH shareholders. Sorry to single you out during this difficult time, but what a great example of what the last few years have been like. 🙏